Traders Buy Large Volume of Call Options on Corteva (NYSE:CTVA)

Corteva, Inc. (NYSE:CTVA) was the target of unusually large options trading on Wednesday. Investors acquired 5,408 call options on the stock. This is an increase of 532% compared to the typical volume of 856 call options.

Corteva Trading Up 2.6%

Shares of NYSE:CTVA traded up $0.36 during mid-day trading on Wednesday, reaching $14.27. 9,930,692 shares of the company were exchanged, compared to its average volume of 6,182,983. Corteva has a 1 year low of $11.74 and a 1 year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The firm’s 50-day simple moving average is $75.82 and its 200 day simple moving average is $79.64. The firm has a market cap of $9.52 billion, a price-to-earnings ratio of 9.44, a P/E/G ratio of 0.38 and a beta of 0.57.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The company’s quarterly revenue was down 1.2% on a year-over-year basis. During the same period last year, the business posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts forecast that Corteva will post 3.72 EPS for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st were issued a $0.18 dividend. The ex-dividend date was Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 5.0%. Corteva’s payout ratio is 47.68%.

Analysts Set New Price Targets

CTVA has been the topic of several research analyst reports. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Morgan Stanley reaffirmed an “overweight” rating and issued a $18.00 price target on shares of Corteva in a research note on Friday, October 2nd. BMO Capital Markets set a $15.00 price objective on Corteva in a report on Friday. UBS Group increased their price objective on shares of Corteva from $85.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, September 16th. Finally, JPMorgan Chase & Co. raised Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 price target for the company in a report on Tuesday. Sixteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and an average target price of $67.45.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of CTVA. BlackRock Inc. acquired a new position in Corteva during the 2nd quarter worth approximately $4,560,180,000. Wellington Management Group LLP raised its holdings in shares of Corteva by 941.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after purchasing an additional 6,881,875 shares in the last quarter. Jupiter Topco LLC acquired a new position in shares of Corteva during the second quarter worth $544,246,000. Bank of America Corp DE acquired a new stake in Corteva in the second quarter valued at $484,927,000. Finally, Legal & General Group Plc acquired a new position in shares of Corteva during the 2nd quarter worth about $482,836,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: JPMorgan upgraded Corteva to Overweight from Neutral and set a $19 price target, implying roughly 34% upside from the cited share price. The firm described the stock as undervalued following the Vylor spinoff. JPMorgan Upgrades Corteva
• Positive Sentiment: KeyBanc also raised Corteva to Overweight, adding to the positive analyst momentum and reinforcing expectations that the post-spinoff company may warrant a higher valuation. KeyBanc Upgrades Corteva
• Positive Sentiment: Bank of America maintained a Buy rating and an $18 target, citing new product launches and expectations for tighter agricultural markets in 2027. The firm believes innovation can offset pressure from older products. Corteva remains a buy
• Positive Sentiment: The series of upgrades prompted reports that Corteva rallied by approximately 9% to 12%, with investors responding to the potential for a simpler business structure, improved focus, and substantial upside to analyst price targets. Corteva Soars on JPMorgan Upgrade
• Neutral Sentiment: Corteva announced that third-quarter 2026 results will be released after the market closes on November 11, followed by a webcast on November 12. The event could provide the next major catalyst and test whether the focused portfolio is improving results. Corteva Third-Quarter Earnings Date
• Negative Sentiment: Some coverage cautions that the recent rally may have moved the shares ahead of fundamentals, raising valuation concerns. Corteva also faces pressure from legacy products and will need successful product launches and stronger agricultural conditions to justify the bullish targets. Could Corteva Turn Its Setup Into Progress

About Corteva

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.